STRM.BIO Employee Directory

Biotechnology ResearchMassachusetts, United States11-50 Employees

STRM.BIO is a Boston-based biotechnology company focused on pre-clinical research that uses extracellular vesicles to deliver gene therapies directly into patients in vivo. Extracellular vesicles are natural carriers of nucleic acids and proteins with innate targeting capabilities and relatively low immunogenicity, offering a non-viral delivery approach that can be manufactured at scale. The company's proprietary EV platform aims to create new therapeutics and improve the effectiveness of existing gene therapies, with an emphasis on addressing rare diseases. Based in Boston, the business operates within the biotechnology research sector and maintains a small, specialized team focused on translating its EV platform into therapies. In 2025, STRM.BIO announced a collaboration with Ginkgo Bioworks to develop in vivo CAR therapies as part of ARPA-H's EMBODY program.

Sign up for free to view info

Company overview Email format